Skip to main content
Top
Published in: Lung 4/2019

01-08-2019 | Idiopathic Pulmonary Fibrosis | INTERSTITIAL LUNG DISEASE

Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis

Authors: Tomoya Sagawa, Takashi Kida, Tohru Inaba, Isao Yokota, Risa Sagawa, Akiko Kasahara, Shunya Kaneshita, Takuya Inoue, Hidetake Nagahara, Kazuki Fujioka, Makoto Wada, Masataka Kohno, Yutaka Kawahito

Published in: Lung | Issue 4/2019

Login to get access

Abstract

We aimed to evaluate the utility of coagulation markers for the prediction of rapidly progressive interstitial lung disease (RP-ILD) in patients with dermatomyositis (DM). In this retrospective study, 29 patients with DM-associated ILD were analyzed. The number of patients with RP-ILD was 15 (52%). The baseline clinical and demographic data and laboratory markers were analyzed to identify predictive factors for RP-ILD.The univariate logistic regression analysis demonstrated that in addition to well-known laboratory markers, such as serum ferritin, KL-6, and lymphocyte counts, a prolonged activated partial thromboplastin time (aPTT) ratio at the time of DM-associated ILD diagnosis was useful for predicting RP-ILD. Moreover, the logistic regression model and receiver operating characteristic curve analysis showed that combinations of the aPTT ratio and well-known laboratory markers were significantly effective in predicting RP-ILD. This study suggested that an association between RP-ILD and the coagulation system exists.
Appendix
Available only for authorised users
Literature
15.
go back to reference Funauchi M, Shimadsu H, Tamaki C et al (2006) Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol 33:903–906PubMed Funauchi M, Shimadsu H, Tamaki C et al (2006) Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol 33:903–906PubMed
Metadata
Title
Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis
Authors
Tomoya Sagawa
Takashi Kida
Tohru Inaba
Isao Yokota
Risa Sagawa
Akiko Kasahara
Shunya Kaneshita
Takuya Inoue
Hidetake Nagahara
Kazuki Fujioka
Makoto Wada
Masataka Kohno
Yutaka Kawahito
Publication date
01-08-2019
Publisher
Springer US
Published in
Lung / Issue 4/2019
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00245-0

Other articles of this Issue 4/2019

Lung 4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.